These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29871679)

  • 1. Qualitative analysis of national documents on health care services and pharmaceuticals` purchasing challenges: evidence from Iran.
    Bastani P; Samadbeik M; Dinarvand R; Kashefian-Naeeini S; Vatankhah S
    BMC Health Serv Res; 2018 Jun; 18(1):410. PubMed ID: 29871679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal and policy requirements of basic health insurance package to achieve universal health coverage in a developing country.
    Hayati R; Kabir MJ; Kavosi Z; Bastani P; Sobhani G; Javadinasab H
    BMC Res Notes; 2019 Sep; 12(1):575. PubMed ID: 31519216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges of implementation: Strategic purchasing in Iran Health Insurance Organization.
    Kalantari AR; Jafari Sirizi M; Mehrolhassani MH; Dehnavieh R
    Int J Health Plann Manage; 2019 Jan; 34(1):e875-e884. PubMed ID: 30408235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social insurance for dental care in Iran: a developing scheme for a developing country.
    Jadidfard MP; Yazdani S; Khoshnevisan MH
    Oral Health Dent Manag; 2012 Dec; 11(4):189-98. PubMed ID: 23208596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resource allocation and purchasing arrangements to improve accessibility of medicines: Evidence from Iran.
    Bastani P; Mehralian G; Dinarvand R
    J Res Pharm Pract; 2015; 4(1):9-17. PubMed ID: 25710045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical strategic purchasing requirements in Iran: Price interventions and the related effective factors.
    Bastani P; Dinarvand R; SamadBeik M; Pourmohammadi K
    J Res Pharm Pract; 2016; 5(1):35-42. PubMed ID: 26985434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Qualitative Assessment of the Evidence Utilization for Health Policy-Making on the Basis of SUPPORT Tools in a Developing Country.
    Hasan Imani-Nasab M; Seyedin H; Yazdizadeh B; Majdzadeh R
    Int J Health Policy Manag; 2017 Aug; 6(8):457-465. PubMed ID: 28812845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Requirements of Strategic Purchasing of Health Services for Cancer Patients: A Qualitative Study in Iran.
    Yaghoubian S; Mahmoudi G; Jahani MA
    Health Care Manag (Frederick); 2020; 39(1):35-45. PubMed ID: 31880674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenges of strategic purchasing of healthcare services in Iran Health Insurance Organization: a qualitative study.
    Gorji HA; Mousavi SMSP; Shojaei A; Keshavarzi A; Zare H
    Electron Physician; 2018 Feb; 10(2):6299-6306. PubMed ID: 29629051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fail to prepare and you can prepare to fail: the experience of financing path changes in teaching hospitals in Iran.
    Doshmangir L; Rashidian A; Jafari M; Ravaghi H; Takian A
    BMC Health Serv Res; 2016 Apr; 16():138. PubMed ID: 27102262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stewardship of National Oral Health system in Iran: its strengths and weaknesses.
    Tahani B; Khoshnevisan MH; Yazdani S; Ebn Ahmady A; Dugdale P
    Arch Iran Med; 2013 Dec; 16(12):717-24. PubMed ID: 24329145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative document analysis on Iranian contents and trends of population policies: Lessons learned and avenues for future.
    Izadi R; Bahrami MA; Sarikhani Y; Bastani P
    Heliyon; 2023 Jun; 9(6):e17377. PubMed ID: 37408904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the potential advantages and disadvantages of merging health insurance funds? A qualitative policy analysis from Iran.
    Bazyar M; Yazdi-Feyzabadi V; Rahimi N; Rashidian A
    BMC Public Health; 2020 Aug; 20(1):1315. PubMed ID: 32867732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stewardship as a Fundamental Challenge in Strategic Purchasing of Health Services: A Case Study of Iran.
    Ghoddoosi-Nejad D; Jannati A; Doshmangir L; Arab-Zozani M; Imani A
    Value Health Reg Issues; 2019 May; 18():54-58. PubMed ID: 30445336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral health policymaking challenges in Iran: a qualitative approach.
    Mohammadpour M; Bastani P; Brennan D; Ghanbarzadegan A; Bahmaei J
    BMC Oral Health; 2020 Jun; 20(1):158. PubMed ID: 32487152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis.
    Olyaaeemanesh A; Jaafaripooyan E; Abdollahiasl A; Davari M; Mousavi SM; Delpasand M
    Health Res Policy Syst; 2021 Dec; 19(1):150. PubMed ID: 34949207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from one year experience of pooled procurement of pharmaceuticals: exploration of indicators and assessing pharmacies` performance.
    Bastani P; Imanieh MH; Dorosti H; Abbasi R; Dashti SA; Keshavarz K
    Daru; 2020 Jun; 28(1):13-23. PubMed ID: 30421278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health insurance benefit package in Iran: a qualitative policy process analysis.
    Mohamadi E; Takian A; Olyaeemanesh A; Rashidian A; Hassanzadeh A; Razavi M; Ghazanfari S
    BMC Health Serv Res; 2020 Aug; 20(1):722. PubMed ID: 32762695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical analysis of purchasing arrangements in Kenya: the case of micro health insurance.
    Munge K; Mulupi S; Barasa E; Chuma J
    BMC Health Serv Res; 2019 Jan; 19(1):45. PubMed ID: 30658639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.
    Davidova J; Praznovcova L; Lundborg CS
    Pharm World Sci; 2008 Jan; 30(1):57-64. PubMed ID: 17588212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.